Literature DB >> 25125304

Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.

Kevin M Trulock1, Sanjiv M Narayan2, Jonathan P Piccini3.   

Abstract

Because nonpharmacological interventions likely alter the risks and benefits associated with rhythm control, this paper reviews the role of current rhythm control strategies in atrial fibrillation. This report also focuses on the specific limitations of pharmacological interventions and the utility of percutaneous ablation in this growing population of patients with concomitant atrial fibrillation and heart failure.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antiarrhythmic drug therapy; atrial fibrillation; catheter ablation; heart failure; rhythm control

Mesh：

Substances：

Year:  2014        PMID： 25125304     DOI： 10.1016/j.jacc.2014.06.1169

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


  30 in total

Review 1.  Tackling Patient-Reported Outcomes in Atrial Fibrillation and Heart Failure: Identifying Disease-Specific Symptoms?

Authors:  Benjamin A Steinberg; Jonathan P Piccini
Journal:  Cardiol Clin       Date:  2019-05       Impact factor: 2.213

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 3.  Atrial Fibrillation in Heart Failure-Diagnostic, Therapeutic, and Prognostic Relevance.

Authors:  Clara Stegmann; Gerhard Hindricks
Journal:  Curr Heart Fail Rep       Date:  2019-08

4.  Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.

Authors:  Jonathan P Piccini; William T Abraham; Christopher Dufton; Ian A Carroll; Jeff S Healey; Dirk J van Veldhuisen; William H Sauer; Inder S Anand; Michel White; Stephen B Wilton; Ryan Aleong; Michiel Rienstra; Steven K Krueger; Felix Ayala-Paredes; Yaariv Khaykin; Bela Merkely; Vladimir Miloradović; Jerzy K Wranicz; Leonard Ilkhanoff; Paul D Ziegler; Gordon Davis; Laura L Emery; Debra Marshall; David P Kao; Michael R Bristow; Stuart J Connolly
Journal:  JACC Heart Fail       Date:  2019-04-29       Impact factor: 12.035

Review 5.  Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Jose F Huizar; Kenneth A Ellenbogen; Alex Y Tan; Karoly Kaszala
Journal:  J Am Coll Cardiol       Date:  2019-05-14       Impact factor: 24.094

6.  Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction.

Authors:  Maojing Wang; Shanglang Cai; Wei Ding; Yujie Deng; Qing Zhao
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

7.  Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Authors:  David R Van Wagoner; Jonathan P Piccini; Christine M Albert; Mark E Anderson; Emelia J Benjamin; Bianca Brundel; Robert M Califf; Hugh Calkins; Peng-Sheng Chen; Nipavan Chiamvimonvat; Dawood Darbar; Lee L Eckhardt; Patrick T Ellinor; Derek V Exner; Richard I Fogel; Anne M Gillis; Jeff Healey; Stefan H Hohnloser; Hooman Kamel; David A Lathrop; Gregory Y H Lip; Reena Mehra; Sanjiv M Narayan; Jeffrey Olgin; Douglas Packer; Nicholas S Peters; Dan M Roden; Heather M Ross; Robert Sheldon; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

Review 8.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

9.  Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation in Patients Hospitalized With Heart Failure.

Authors:  Subir Bhatia; Mohammad Qazi; Ashwini Erande; Kunjan Shah; Alpesh Amin; Pranav Patel; Shaista Malik
Journal:  Am J Cardiol       Date:  2016-02-17       Impact factor: 2.778

Review 10.  Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.

Authors:  Kishan S Parikh; Jonathan P Piccini
Journal:  Curr Heart Fail Rep       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.